LAURA CUNNINGHAM: Open Payments
NPI 1841735388 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 39 payments from 13 companies in 2025. Trend: 2023 $330 · 2024 $604 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $256 |
| GENZYME CORPORATION | 9 | $184 |
| Dexcom, Inc. | 1 | $153 |
| ABBVIE INC. | 1 | $126 |
| Exact Sciences Corporation | 1 | $120 |
| Smith+Nephew, Inc. | 1 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Melinta Therapeutics, LLC | 3 | $48 |
| Genentech USA, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: NUCALA, DUPIXENT, Dexcom G6 Transmitter, AVYCAZ, The Cologuard Plus Collection Kit, HALO, Kimyrsa, TEZSPIRE.
Industry payments across KS — which companies pay providers there.
